SRSF3 and liver disorder: Consequently, it is likely that SRSF3 presents low expression and tumor-suppressor activity in mouse liver disease, while it shows high expression and acts as an oncogene in human HCC, suggesting its role as an unfavorable prognostic predictor in HCC.